Research output per year
Research output per year
Personal profile
Education
- 國立成功大學醫學系學士
Experience
- 2016年08月 ~迄今 胸腔內科醫師
- 2011年08月 ~2016年07月 內科部住院醫師
Fingerprint
Dive into the research topics where Wei-Yuan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 4 Article
-
Extracellular vesicle mir-200c enhances gefitinib sensitivity in heterogeneous egfr-mutant nsclc
Lin, C. C., Wu, C. Y., Tseng, J. T. C., Hung, C. H., Wu, S. Y., Huang, Y. T., Chang, W. Y., Su, P. L. & Su, W. C., 2021 Mar, In: Biomedicines. 9, 3, 243.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 Oct 1, In: Cancer medicine. 8, 13, p. 5939-5947 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus) -
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
Su, P. L., Wu, Y. L., Chang, W. Y., Ho, C. L., Tseng, Y. L., Lai, W. W., Su, W. C., Lin, C. C. & Yang, S. C., 2018 Jan 1, In: Therapeutic Advances in Medical Oncology. 10Research output: Contribution to journal › Article › peer-review
Open Access27 Citations (Scopus) -
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
Chang, W. Y., Wu, Y. L., Su, P. L., Yang, S. C., Lin, C. C. & Su, W. C., 2018 Feb, In: PloS one. 13, 2, e0192161.Research output: Contribution to journal › Article › peer-review
Open Access24 Citations (Scopus)